Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine

Cardiovascular Therapeutics

Volumn 26, Issue 2, 2008, Pages 147-165

  Onay Besikci, A ^a   Ozkan S A ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cardiac metabolism; Electrochemistry; GC; HPLC; Spectrophotometry; Trimetazidine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; LACTATE DEHYDROGENASE; MALONALDEHYDE; NIFEDIPINE; NITRIC ACID DERIVATIVE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA; VERAPAMIL;

ANALYTIC METHOD; ANGINA PECTORIS; AREA UNDER THE CURVE; CARDIOMYOPATHY; CHEMOLUMINESCENCE; CLINICAL TRIAL; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; DRUG UTILIZATION; ELECTROSPRAY MASS SPECTROMETRY; FLOW INJECTION ANALYSIS; GAIT DISORDER; GAS CHROMATOGRAPHY; HEADACHE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; TREMOR; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR AGENTS; CHEMILUMINESCENT MEASUREMENTS; CHEMISTRY, ANALYTICAL; CHROMATOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; ELECTROCHEMISTRY; ENERGY METABOLISM; FLOW INJECTION ANALYSIS; HEART DISEASES; HUMANS; ISCHEMIA; MYOCARDIAL CONTRACTION; MYOCARDIUM; REACTIVE OXYGEN SPECIES; SPECTROPHOTOMETRY; TRIMETAZIDINE;

EID: 46749142610     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2008.00043.x     Document Type: Review

References (179)

1. Abou-Attia FM, Issa YM, Abdel-Gawad FM, Abdel-Hamid SM (2003) Quantitative determination of some pharmaceutical piperazine derivatives through complexation with iron (III) chloride. Farmaco 58 : 573 579.
2. Adamovics JA (1997) Chromatographic analysis of pharmaceuticals, 2nd Edition. New York : Marcel Dekker.
3. Ahuja S, Scypinski S (2001) Handbook of modern pharmaceutical analysis, Vol. 3. London : Academic Press.
4. Alemu H (2004) Voltammetry of drugs at the interface between two immiscible electrolyte solutions. Pure Appl Chem 76 : 697 705.
5. Allibardi S, Chierchia SL, Margonato V, Merati G, Neri G, Dell'Antonio G, Samaja M (1998) Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts. Cardiovasc Drugs Ther 12 : 543 549.
6. Altiokka G, Kircali K, Aboul-Enein HY (2006) Rapid HPLC and direct flow injection analysis assay for the determination of trimetazidine HCL in pharmaceutical tablet formulation. J Liq Chromatogr Relat Technol 29 : 2245 2255.
7. Argaud L, Gomez L, Gateau-Roesch O, Couture-Lepetit E, Loufouat J, Robert D, Ovize M (2005) Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J Mol Cell Cardiol 39 : 893 899.
8. Asano M, Ohkubo C, Sawanobori K, Yonekawa K (1980) Cutaneous microcirculatory effects of various vasodilator agents on the conscious rabbit, with special regard to changes in the rhythmic property of vasomotion. Biochem Exp Bio 16 : 341 348.
9. Aubert A, Bernard C, Clauser P, Harpey C, Vaudry H (1989) Effect of phenazine methosulfate on electrophysiological activity of the semicircular canal: Antioxidant properties of trimetazidine. Eur J Pharmacol 174 : 215 225.
10. Aussedat J, Ray A, Kay L, Verdys M, Harpey C, Rossi A (1993) Improvement of long-term preservation of isolated arrested rat heart: Beneficial effect of the antiischemic agent trimetazidine. J Cardiovasc Pharmacol 21 : 128 135.
11. Bari VR, Dhorda UJ, Sundaresan M (1999) Trace determination of trimetazidine hydrochloride in human blood plasma by HPLC using electrochemical detection. Indian Drugs 36 : 289 292.
12. Barré J, Ledudal P, Oosterhuis B, Brakenhoff JP, Wilkens G, Sollie FA, Tran D (2003) Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure. Biopharm Drug Dispos 24 : 159 164.
13. Baumert H, Faure JP, Zhang K, Petit I, Goujon JM, Dutheil D, Favreau F, Barrière M, Tillement JP, Mauco G, et al 2004) Evidence for a mitochondrial impact of trimetazidine during cold ischemia and reperfusion. Pharmacology 71 : 25 37.
14. Baumert H, Goujon JM, Richer JP, Lacoste L, Tillement JP, Eugene M, Carretier M, Hauet T (1999) Renoprotective effects of trimetazidine against ischemia-reperfusion injury and cold storage preservation: A preliminary study. Transplantation 68 : 300 303.
15. Bayram A, Atalay C, Kocatürk H, Yücel O (2005) Effects of trimetazidine on lipid peroxidation, antioxidant enzyme activities and plasma brain natriuretic peptide levels in patients with chronic cor pulmonale. J Int Med Res 33 : 612 619.
16. Bebawy LI, El Tarras MF, El Sabour SA (2004) Determination of trimetazidine dihydrochloride in the presence of its acid-induced degradation products. J AOAC Int 87 : 827 833.
17. Belardinelli R, Purcaro A (2001) Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 22 : 2164 2170.
18. Belcher PR, Drake-Holland AJ, Hynd JW, Noble MI (1993) Effects of trimetazidine on in vivo coronary arterial platelet thrombosis. Cardiovasc Drugs Ther 7 : 149 157.
19. Ben Mosbah I, Casillas-Ramírez A, Xaus C, Serafín A, Roselló-Catafau J, Peralta C (2006) Trimetazidine: Is it a promising drug for use in steatotic grafts World J Gastroenterol 12 : 908 914.
20. Birand A, Kudaiberdieva GZ, Batyraliev TA, Akgul F, Usal A (1997) Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty. Angiology 48 : 413 422.
21. Blardi P, de Lalla A, Volpi L, Auteri A, Di Perri T (2002) Increase of adenosine plasma levels after oral trimetazidine: A pharmacological preconditioning Pharmacol Res 45 : 69 72.
22. Boucher FR, Hearse DJ, Opie LH (1994) Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts. J Cardiovasc Pharmacol 24 : 45 49.
23. Brottier L, Barat JL, Combe C, Boussens B, Bonnet J, Bricaud H (1990) Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Heart J 11 : 207 212.
24. Cano C, Bermúdez VJ, Medina MT, Bermúdez FA, Ambard MJ, Souki AJ, Escalona D, Contreras F, Velasco M (2003) Trimetazidine diminishes fasting glucose in rats with fasting hyperglycemia: A preliminary study. Am J Ther 10 : 444 446.
25. Chazov EI, Lepakchin VK, Zharova EA, Fitilev SB, Levin AM, Rumiantzeva EG, Fitileva TB (2005) Trimetazidine in Angina Combination Therapy - the TACT study: Trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study. Am J Ther 12 : 35 42.
26. Christian GD (2004) Analytical chemistry, 6th Edition. New Jersey : John Wiley & Sons Inc.
27. Courte S, Bromet N (1981) Trace determination of trimetazidine in plasma by high-performance liquid chromatography using fluorescence detection. J Chromatogr 224 : 162 167.
28. Creagh T, Lanigan D, Dolan J, Tormey W, Walshe JJ, Bouchier-Hayes DJ (1993) Pharmacological manipulation of acute cyclosporin ischemic renal injury with trimetazidine. J Urol 149 : 915 917.
29. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A (1990) Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study. Cardiovasc Drugs Ther 4 : 853 859.
30. Darwish IA (2005) Kinetic spectrophotometric methods for determination of trimetazidine dihydrochloride. Anal Chim Acta 551 : 222 231.
31. de Jager AD, Sutherland FCW, Badenhorst D, Hundt HKL, Swart KJ, Scanes T, Hundt AF (2001) High throughput assay method for the quantitation of trimetazidine in human plasma by LC/MS, with selected reaction monitoring. J Liq Chromatogr Relat Technol 24 : 2121 2132.
32. Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P (1994) Trimetazidine: A new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol 37 : 279 288.
33. Devynck MA, Le Quan Sang KH, Joulin Y, Mazeud M (1993) Acute membrane effects of trimetazidine in human platelets. Eur J Pharmacol 245 : 105 110.
34. D'hahan N, Taouil K, Dassouli A, Morel JE (1997) Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6. Eur J Pharmacol 328 : 163 174.
35. D'hahan N, Taouil K, Janmot C, Morel JE (1998) Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype. Br J Pharmacol 123 : 611 616.
36. Di Napoli P, Chierchia S, Taccardi AA, Grilli A, Felaco M, De Caterina R, Barsotti A (2007a) Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts. Nitric Oxide 16 : 228 236.
37. Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A (2007b) Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. Am Heart J 154 : 602.e1 602.e5.
38. Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A (2007c) Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: A post hoc analysis of the Villa Pini D'Abruzzo Trimetazidine Trial. J Cardiovasc Pharmacol 50 : 585 589.
39. Di Napoli P, Taccardi AA, Barsotti A (2005) Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart 91 : 161 165.
40. Di Pasquale P, Lo Verso P, Bucca V, Cannizzaro S, Scalzo S, Maringhini G, Rizzo R, Paterna S (1999) Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: Short-term and long-term results. Cardiovasc Drugs Ther 13 : 423 428.
41. Ding L, Gong B, Chu X, Hu J, Zheng H (2007) Sensitive and rapid LC-ESI-MS method for the determination of trimetazidine in human plama. J Pharm Biomed Anal 44 : 526 531.
42. Dogan A, Ozaydin M, Gedikli O, Altinbas A, Ergene O (2003) Effect of trimetazidine on exercise performance in patients with coronary artery ectasia. Jpn Heart J 44 : 463 470.
43. Drake-Holland AJ, Belcher PR, Hynd J, Noble MI (1993) Infarct size in rabbits: A modified method illustrated by the effects of propranolol and trimetazidine. Basic Res Cardiol 88 : 250 258.
44. El Banani H, Bernard M, Baetz D, Cabanes E, Cozzone P, Lucien A, Feuvray D (2000) Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia. Cardiovasc Res 47 : 688 696.
45. El Banani H, Bernard M, Cozzone P, James F, Feuvray D (1998) Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury. Am J Cardiol 82 : 25K 29K.
46. Elimadi A, Morin D, Sapena R, Chauvet-Monges AM, Crevat A, Tillement JP (1997) Comparison of the effects of cyclosporine A and trimetazidine on Ca(2+)-dependent mitochondrial swelling. Fundam Clin Pharmacol 11 : 440 447.
47. Elimadi A, Settaf A, Morin D, Sapena R, Lamchouri F, Cherrah Y, Tillement JP (1998) Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function. J Pharmacol Exp Ther 286 : 23 28.
48. Fabiani JN, Farah B, Vuilleminot A, Lecompte T, Emerit I, Chardigny C, Carpentier A (1993) Chromosomal aberrations and neutrophil activation induced by reperfusion in the ischaemic human heart. Eur Heart J 14 : 12 17.
49. Fabiani JN, Ponzio O, Emerit I, Massonet-Castel S, Paris M, Chevalier P, Jebara V, Carpentier A (1992) Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg (Torino) 33 : 486 491.
50. Fantini E, Athias P, Demaison L, Grynberg A (1997) Protective effects of trimetazidine on hypoxic cardiac myocytes from the rat. Fundam Clin Pharmacol 11 : 427 439.
51. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P (1994) Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 26 : 949 958.
52. Faure JP, Baumert H, Han Z, Goujon JM, Favreau F, Dutheil D, Petit I, Barriere M, Tallineau C, Tillement JP, et al 2003) Evidence for a protective role of trimetazidine during cold ischemia: Targeting inflammation and nephron mass. Biochem Pharmacol 66 : 2241 2250.
53. Fay L, Michel G, Goupit P, Harpey C, Prost M (1989) Determination of trimetazidine in biological fluids by gas chromatography-mass spectrometry. J Chromatogr 490 : 198 205.
54. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A (2006) Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 27 : 942 948.
55. Fragasso G, Piatti PM, Monti L, Palloshi A, Lu C, Valsecchi G, Setola E, Calori G, Pozza G, Margonato A, et al 2002) Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: Evaluation of the protective role of the metabolic modulator trimetazidine. J Am Coll Cardiol 39 : 413 419.
56. Fragasso G, Piatti PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A (2003) Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J 146 : E18.
57. Gambert S, Vergely C, Filomenko R, Moreau D, Bettaieb A, Opie LH, Rochette L (2006) Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts. Mol Cell Biochem 283 : 147 152.
58. Génissel P, Chodjania Y, Demolis JL, Ragueneau I, Jaillon P (2004) Assessment of the sustained release properties of a new oral formulation of trimetazidine in pigs and dogs and confirmation in healthy human volunteers. Eur J Drug Metab Pharmacokinet 29 : 61 68.
59. Ghoneim MM, Khashaba PY, Beltagi AM (2002) Determination of trimetazidine HCL by adsorptive stripping square-wave voltammetry at a glassy carbon electrode. J Pharmaceut Biomed Anal 27 : 235 241.
60. Goujon JM, Vandewalle A, Baumert H, Carretier M, Hauet T (2000) Influence of cold-storage conditions on renal function of autotransplanted large pig kidneys. Kidney Int 58 : 838 850.
61. Grekas D, Dioudis C, Papageorgiou G, Iliadis S, Zilidis C, Alivanis P, Dimitriadou A, Tourkantonis A (1996) Lipid peroxidation after acute renal ischemia and reperfusion in rats: The effect of trimetazidine. Ren Fail 18 : 545 552.
62. Guarnieri C, Muscari C (1988) Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats. Biochem Pharmacol 37 : 4685 4688.
63. Guarnieri C, Muscari C (1989) Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats. Res Commun Chem Pathol Pharmacol 64 : 215 225.
64. Guarnieri C, Muscari C (1993) Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 46 : 324 331.
65. Guler N, Eryonucu B, Gunes A, Guntekin U, Tuncer M, Ozbek H (2003) Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction. Cardiovasc Drugs Ther 17 : 371 374.
66. Hart JP (1990) Electroanalysis of biologically important compounds. New York : Ellis Horwood Publishers
67. Hauet T, Baumert H, Amor IB, Gibelin H, Tallineau C, Eugene M, Tillement JP, Carretier M (2000a) Pharmacological limitation of damage to renal medulla after cold storage and transplantation by trimetazidine. J Pharmacol Exp Ther 292 : 254 260.
68. Hauet T, Baumert H, Mothes D, Germonville T, Caritez JC, Carretier M, Journe F, Eugene M, Tillement JP (1998a) Lipid peroxidation after cold storage and normothermic reperfusion: The effect of trimetazidine. Transpl Int 11 : S408 S409.
69. Hauet T, Bauza G, Goujon JM, Caritez JC, Carretier M, Eugene M, Tillement JP (1998b) Effects of trimetazidine on lipid peroxidation and phosphorus metabolites during cold storage and reperfusion of isolated perfused rat kidneys. J Pharmacol Exp Ther 285 : 1061 1067.
70. Hauet T, Bauza G, Mothes D, Le Moyec L, Goujon JM, Dore B, Caritez JC, Carretier M, Eugene M, Tillement JP (1997a) Beneficial effect on rat kidney preservation of the antiischemic agent trimetazidine during cold storage and reperfusion: Assessment by 31P nuclear magnetic resonance spectroscopy. Transplant Proc 29 : 2343 2344.
71. Hauet T, Goujon JM, Vandewalle A, Baumert H, Lacoste L, Tillement JP, Eugene M, Carretier M (2000b) Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 11 : 138 148.
72. Hauet T, Mothes D, Goujon JM, Caritez JC, Carretier M, le Moyec L, Eugene M, Tillement JP (1997b) Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischemia. Transplantation 64 : 1082 1086.
73. Hauet T, Mothes D, Goujon JM, Germonville T, Caritez JC, Carretier M, Eugene M, Tillement J (1998c) Trimetazidine reverses deleterious effects of ischemia-reperfusion in the isolated perfused pig kidney model. Nephron 80 : 296 304.
74. Hauet T, Tallineau C, Goujon JM, Carretier M, Eugene M, Tillement JP (1998d) Efficiency of trimetazidine in renal dysfunction secondary to cold ischemia-reperfusion injury: A proposed addition to University of Wisconsin solution. Cryobiology 37 : 231 244.
75. Hugtenburg JG, Jap TJ, Mathy MJ, van Heiningen PN, Bohnenn VA, Heijnis JB, Boddeke HW, van Zwieten PA (1989) Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischaemia. Arch Int Pharmacodyn Ther 300 : 186 208.
76. Ikizler M, Erkasap N, Dernek S, Batmaz B, Kural T, Kaygisiz Z (2006) Trimetazidine-induced enhancement of myocardial recovery during reperfusion: A comparative study in diabetic and non-diabetic rat hearts. Arch Med Res 37 : 700 708.
77. Imai Y, Himori N, Taira N (1977) Cardiohemodynamic effects of SK&F 24260, D 600, diltiazem, dilazep, and trimetazidine in the dog. Jpn Heart J 18 : 120 131.
78. Inci I, Dutly A, Inci D, Boehler A, Weder W (2001) Recipient treatment with trimetazidine improves graft function and protects energy status after lung transplantation. J Heart Lung Transplant 20 : 1115 1122.
79. Iskit AB, Guc MO (1996) Thimerosal attenuates ischaemia-reperfusion arrhythmias in rats: No modification by anti-ischaemic agent trimetazidine or endothelin receptor antagonist bosentan. Pharmacol Res 34 : 17 23.
80. Issa YM, Abdel-Ghani NT, Ahmed HM (2005) Flow injection analysis with trimetazidine dihydrochloride ion-selective electrode. Sci Pharm 74 : 173 193.
81. Issa YM, Abou-Attia FM, Abdel-Gawad FM, Abdel-Hamid SM (2002a) Spectrophotometric determination of some pharmaceutical piperazine derivatives by charge-transfer and ion-pair complexation methods. Sci Pharm 70 : 253 269.
82. Issa YM, Abou-Attia FM, Abdel-Gawad FM, Abdel-Hamid SM (2002b) Utility of some ∏-acceptors for the spectrophotometric determination of trimetazidine hydrochloride. Anal Lett 35 : 451 461.
83. Jeoung MK, Kim KS, Kim CS, Kim NH, Chung YB, Hong JT, Moon DC (2005) An HPLC determination of trimetazidine in human plasma using liquid-liquid extraction for sample clean-up. J Liq Chromatogr Relat Technol 28 : 1299 1309.
84. Jiao Y, Su MM, Chen MJ, Jia W, Chou Y, Huang ZY, Yang N, Tong W (2007a) LC/ESI-MS method for the determination of trimetazidine in human plasma: Application to a bioequivalence study on Chinese volunteers. J Pharm Biomed Anal 43 : 1804 1807.
85. Jiao Y, Su MM, Chen MJ, Jia W, Tao P, Qui YQ, Huang ZY (2007b) Determination of trimetazidine in human plasma by high performance liquid chromatography-mass spectrometry. Chin J Anal Chem 35 : 541 544.
86. Kantor PF, Lucien A, Kozak R, Lopaschuk GD (2000) The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86 : 580 588.
87. Kara AF, Demiryurek S, Celik A, Tarakçioǧlu M, Demiryurek AT (2004) Effects of trimetazidine on myocardial preconditioning in anesthetized rats. Eur J Pharmacol 503 : 135 145.
88. Kara AF, Demiryurek S, Celik A, Tarakcioǧlu M, Demiryurek AT (2006) Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats. Fundam Clin Pharmacol 20 : 449 559.
89. Kaur H, Padi SS, Chopra K (2003) Attenuation of renal ischemia-reperfusion injury by trimetazidine: Evidence of an in vivo antioxidant effect. Methods Find Exp Clin Pharmacol 25 : 803 809.
90. Kay L, Finelli C, Aussedat J, Guarnieri C, Rossi A (1995) Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine: Effects on the energy state and mitochondrial function. Am J Cardiol 76 : 45B 49B.
91. Kaya Y, Coskun T, Aral E, Erkasap N, Var A (2003) The effect of trimetazidine on liver regeneration after partial hepatectomy under hepatic blood inflow occlusion. Hepatogastroenterology 50 : 651 655.
92. Kennedy JA, Horowitz JD (1998) Effect of trimetazidine on carnitine palmitoyltransferase-1 in the rat heart. Cardiovasc Drugs Ther 12 : 359 363.
93. Khedr A, Sheha MM, Darwish IA (2007) Sensitive determination of trimetazidine in spiked human plasma by HPLC with fluorescence detection after pre-column derivatization with 9-fluorenylmethyl chloroformate. J Chromatogr B 856 : 337 342.
94. Kiyosue T, Nakamura S, Arita M (1986) Effects of trimetazidine on action potentials and membrane currents of guinea-pig ventricular myocytes. J Mol Cell Cardiol 18 : 1301 1311.
95. Kober G, Buck T, Sievert H, Vallbracht C (1992) Myocardial protection during percutaneous transluminal coronary angioplasty: Effects of trimetazidine. Eur Heart J 13 : 1109 1115.
96. Komori S, Ishii M, Hashimoto K (1985) Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models. Jpn J Pharmacol 38 : 73 82.
97. Kountouris E, Pappa E, Pappas K, Dimitroula V, Karanikis P, Tzimas T, Siogas K (2001) Metabolic management of coronary heart disease: Adjunctive treatment with trimetazidine decreases QT dispersion in patients with a first acute myocardial infarction. Cardiovasc Drugs Ther 15 : 315 321.
98. Krishnamoorthy G, Ganesh M (2001) Spectrophotometric determination of trimetazidine dihydrochloride in bulk and solid dosage forms. Indian J. Pharm. Sci. 63 : 436 437.
99. Kuralay F, Altekin E, Yazlar AS, Onvural B, Goldeli O (2006) Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine. Tohoku J Exp Med 208 : 203 212.
100. Lavanchy N, Martin J, Rossi A (1987) Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 286 : 97 110.
101. Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL (1999) Comparison of trimetazidine with atenolol in patients with syndrome X: Effects on diastolic function and exercise tolerance. Cardiologia 44 : 1065 1069.
102. Levy S (1995) Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators. Am J Cardiol 76 : 12B 16B.
103. Lopaschuk GD, Barr R, Thomas PD, Dyck JR (2003) Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 93 : e33 e37.
104. Lu C, Dabrowski P, Fragasso G, Chierchia SL (1998) Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol 82 : 898 901.
105. MacInnes A, Fairman DA, Binding P, Rhodes J, Wyatt MJ, Phelan A, Haddock PS, Karran EH (2003) The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 93 : e26 e32.
106. Manchanda SC (2003) Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine. Int J Cardiol 88 : 83 89.
107. Manchanda SC, Krishnaswami S (1997) Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 78 : 353 357.
108. Maridonneau-Parini I, Harpey C (1985) Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 20 : 148 151.
109. Martí Massó JF, Martí I, Carrera N, Poza JJ, López de Munain A (2005) Trimetazidine induces parkinsonism, gait disorders and tremor. Therapie 60 : 419 422.
110. Martindale (2005). The complete drug reference, 34th Edition. In : Sean C. Sweetman, ed. London : Pharmaceutical Press.
111. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C (1990) Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart. Cardiovasc Drugs Ther 4 : 791 795.
112. McClellan KJ, Plosker GL (1999) Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions. Drugs 58 : 143 157.
113. Medvedovici A, Albu F, Georgita C, David V (2005) Non-extractive procedure followed by LC-APCI MS/MS analysis of trimetazidine in plasma samples for assessing bioequivalence of immediate/modified release formulations. Biomed Chromatogr 19 : 549 555.
114. Meng D, Feng L, Chen XJ, Yang D, Zhang JN (2006) Trimetazidine improved Ca2+ handling in isoprenaline-mediated myocardial injury of rats. Exp Physiol 91 : 591 601.
115. Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, Sack MN (2000) Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: Support for a mitochondrial role in cardioprotection. Cardiovasc Res 47 : 68 73.
116. Minota S, Koketsu K (1976) The actions of trimetazidine on nerve and muscle cells in frogs. Arch Int Pharmacodyn Ther 220 : 51 61.
117. Mody FV, Singh BN, Mohiuddin IH, Coyle KB, Buxton DB, Hansen HW, Sumida R, Schelbert HR (1998) Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: An evaluation by positron emission tomography. Am J Cardiol 82 : 42K 49K.
118. Mohand-Said S, Jacquet A, Lucien A, Espinasse-Berrod MA, Frasson Correa De Silva M, Sahel J (2002) Protective effect of trimetazidine in a model of ischemia-reperfusion in the rat retina. Ophthalmic Res 34 : 300 305.
119. Monteiro P, Duarte AI, Gonçalves LM, Moreno A, Providência LA (2004) Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia. Eur J Pharmacol 503 : 123 128.
120. Monti LD, Allibardi S, Piatti PM, Valsecchi G, Costa S, Pozza G, Chierchia S, Samaja M (2001) Triglycerides impair postischemic recovery in isolated hearts: Roles of endothelin-1 and trimetazidine. Am J Physiol 281 : H1122 H1130.
121. Morgan EE, Young ME, McElfresh TA, Kung TA, Hoit BD, Chandler MP, Stanley WC (2006) Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure. Fundam Clin Pharmacol 20 : 503 505.
122. Morillas Blasco PJ, Hernándiz Martinez A, Azorín Villena I, Portolés Sanz M, Pallarés Carratala V, Martinez VB, Capdevilla Carbonell C, Aguilar Llopis A, Cosín Aguilar J (2005) Mitochondrial changes induced by trimetazidine in the myocardium. Med Sci Monit 11 : BR162 BR167.
123. Morin D, Elimadi A, Sapena R, Crevat A, Carrupt PA, Testa B, Tillement JP (1998) Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore. Br J Pharmacol 123 : 1385 1394.
124. Morin D, Sapena R, Elimadi A, Testa B, Labidalle S, Le Ridant A, Tillement JP (2000) [(3)H]-trimetazidine mitochondrial binding sites: Regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance. Br J Pharmacol 130 : 655 663.
125. Murthy TK, Sankar GD, Rao YS (2002a) Spectrophotometric determination of trimetazidine dihydrochloride in pharmaceutical preparations. Asian J Chem 14 : 169 172.
126. Murthy TK, Sankar GD, Rao YS (2002b) Visible spectrophotometric methods for the determination of trimetazidine dihydrochloride in pharmaceutical formulations. Indian Drugs 39 : 230 233.
127. Nowak P, Zagził T, Konecki J, Szczerbak G, Szkilnik R, Niwiński J, Gorzałek J, Kostrzewa RM, Brus R (2006) Trimetazidine increases [3H]glucose uptake in rat brain. Pharmacol Rep 58 : 559 561.
128. Ohannesian L, Streeter AJ (2002) Handbook of pharmaceutical analysis, New York : Marcel Dekker, Inc.
129. Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM (2007) The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Can J Physiol Pharmacol 85 : 527 535.
130. Ovide-Bordeaux S, Bescond-Jacquet A, Grynberg A (2005) Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: Targeting membrane homeostasis with trimetazidine. Clin Exp Pharmacol Physiol 32 : 1061 1070.
131. Ozdemir R, Tuncer C, Aladag M, Guven A, Sezgin AT, Pekdemir H, Korkmaz ME, Muderrisoglu H (1999) Effect of trimetazidine on late potentials after acute myocardial infarction. Cardiovasc Drugs Ther 13 : 145 149.
132. Ozden A, Aybek Z, Saydam N, Calli N, Saydam O, Düzcan E, Güner G (1998) Cytoprotective effect of trimetazidine on 75 min warm renal ischemia-reperfusion injury in rats. Eur Surg Res 30 : 227 234.
133. Ozden S, Kildaci B, Muftuoglu S, Cakar N, Yildirim C (2001) Effect of trimetazidine on retinal ischemia/reperfusion injury in rats. Ophthalmologica 215 : 309 317.
134. Ozkan SA (2007) LC-EC detection and recent application on pharmaceuticals and biological fluids. Chromatographia 66 : S3 S13.
135. Ozkan SA, Uslu B, Aboul-Enein HY (2003) Analysis of pharmaceuticals and biological fluids using modern electroanalytical techniques. Crit Rev Anal Chem 33 : 155 181.
136. Palilis LP, Calokerinos AC (2000) Analytical applications of chemiluminogenic reaction. Anal Chim Acta 413 : 175 186.
137. Papadopoulos CL, Kanonidis IE, Kotridis PS, Papayannis IL, Savatis SC, Missopoulou-Kokka AI, Nikolaidis NK, Koukoulekidis GN, Sakadamis GC (1996) The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction. Int J Cardiol 55 : 137 142.
138. Payet O, D'Aldin C, Maurin L, Bonne C, Muller A (2004) Anti-excitotoxic activity of trimetazidine in the retina. J Ocul Pharmacol Ther 20 : 85 92.
139. Poloński L, Dec I, Wojnar R, Wilczek K (2002) Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty. Curr Med Res Opin 18 : 389 396.
140. Pornin M, Harpey C, Allal J, Sellier P, Ourbak P (1994) Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: A placebo-controlled study. Clin Trials Metaanal 29 : 49 56.
141. Pudil R, Pidrman V, Krejsek J, Gregor J, Tichý M, Andrýs C, Drahosová M, Bláha V (2001) The effect of trimetazidine on C-reactive protein, cytokines and adhesion molecules in the course of acute myocardial infarction. Acta Medica (Hradec Kralove) 44 : 135 140.
142. Rahman F, Toshima Y, Kohno H, Kinoshita K, Tokunaga K (1989) The protective effects of trimetazidine on normothermic ischemic myocardium in rats. Jpn J Surg 19 : 346 350.
143. Renaud JF (1988) Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drugs Ther 1 : 677 686.
144. Reymond F, Steyaert G, Carrupt PA, Morin D, Tillement JP, Girault HH, Testa B (1999) The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis. Pharm Res 16 : 616 624.
145. Rogacka D, Guzik P, Wykretowicz A, Rzeźniczak J, Dziarmaga M, Wysocki H (2000) Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: A preliminary study. Coron Artery Dis 11 : 171 177.
146. Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M (2003) Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: A double-blind placebo-controlled study. Cardiovasc Diabetol 2 : 16
147. Ruixing Y, Wenwu L, Al-Ghazali R (2007) Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion. Transl Res 149 : 152 160.
148. Ruzyllo W, Szwed H, Sadowski Z, Elikowski W, Grzelak-Szafranska H, Orszulak W, Szymczak K, Winter M (2004) Efficacy of trimetazidine in patients with recurrent angina: A subgroup analysis of the TRIMPOL II study. Curr Med Res Opin 20 : 1447 1454.
149. Saeedi R, Grist M, Wambolt RB, Bescond-Jacquet A, Lucien A, Allard MF (2005) Trimetazidine normalizes postischemic function of hypertrophied rat hearts. J Pharmacol Exp Ther 314 : 446 454.
150. Saito D (1976) Effect of coronary vasodilators on cardiac dynamics of the normal dog and the dog with experimental coronary sclerosis. Jpn Circ J 40 : 363 397.
151. Salducci MD, Chauvet-Monges AM, Tillement JP, Albengres E, Testa B, Carrupt P, Crevat A (1996) Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria. J Pharmacol ExpTher 277 : 417 422.
152. Satyanarayana PS, Chopra K (2002) Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: Attenuation by trimetazidine. Ren Fail 24 : 259 274.
153. Sellier P, Broustet JP (2003) Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: A multicenter, double-blind, placebo-controlled study. Am J Cardiovasc Drugs 3 : 361 369.
154. Sentex E, Héliès-Toussaint C, Rousseau D, Lucien A, Ferrary E, Grynberg A (2001) Influence of trimetazidine on the synthesis of complex lipids in the heart and other target organs. Fundam Clin Pharmacol 15 : 255 264.
155. Sentex E, Sergiel JP, Lucien A, Grynberg A (1997) Trimetazidine increases phospholipid turnover in ventricular myocyte. Mol Cell Biochem 175 : 153 162.
156. Settaf A, Morin D, Lamchouri F, Elimadi A, Cherrah Y, Tillement JP (1999) Trimetazidine ameliorates the hepatic injury associated with ischaemia-reperfusion in rats. Pharmacol Res 39 : 211 216.
157. Shirahase H, Suzuki Y, Osumi S, Kakeya N, Kurahashi K (1988) Inhibitory effects of trimetazidine dihydrochloride on aggregation, serotonin release and malondialdehyde production in rabbit platelets. Jpn J Pharmacol 47 : 29 34.
158. Smyth MR, Vos JG (1992) Analytical voltammetry, Vol. 27. New York : Elsevier Science.
159. Steg PG, Grollier G, Gallay P, Morice M, Karrillon GJ, Benamer H, Kempf C, Laperche T, Arnaud P, Sellier P, et al 2001) LIST Study Group. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol 77 : 263 273.
160. Synder LR, Kirkland JJ, Glajch JL (1997) Practical HPLC method development, 2nd Edition. New York : John Wiley and Sons, Inc.
161. Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, Skibińska E, Szymczak K, Swiatek J, Winter M (2001) Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J 22 : 2267 2274.
162. Szwed H, Sadowski Z, Pachocki R, Domzał-Bocheńska M, Szymczak K, Szydłowski Z, Paradowski A, Gajos G, Kałuza G, Kulon I, et al 1999) The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1. Cardiovasc Drugs Ther 13 : 217 222.
163. Tabbi-Anneni I, Helies-Toussaint C, Morin D, Bescond-Jacquet A, Lucien A, Grynberg A (2003a) Prevention of heart failure in rats by trimetazidine treatment: A consequence of accelerated phospholipid turnover? J Pharmacol Exp Ther 304 : 1003 1009.
164. Tabbi-Anneni I, Lucien A, Grynberg A (2003b) Trimetazidine effect on phospholipid synthesis in ventricular myocytes: Consequences in alpha-adrenergic signaling. Fundam Clin Pharmacol 17 : 51 59.
165. Taira N, Imai Y, Hiwatari M (1980) Differential effects of nitroglycerin, trimetazidine, verapamil and SK&F 24260 on venous return as revealed by the open-loop method in the dog. Jpn J Pharmacol 30 : 449 461.
166. Tetik A, Ozden A, Calli N, Bilgihan A, Bostanci B, Yis O, Bayramoglu H (1999) Cytoprotective effect of trimetazidine on 60 minutes of intestinal ischemia-reperfusion injury in rats. Transpl Int 12 : 108 112.
167. The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th Edition. O'Neil MJ, Smith A, Heckelman PE, Budavani S, eds. Whitehouse Station, NJ : John Wiley & Sons.
168. Thoppil SO, Amin PD (2001) Trimetazidine: Stability indicating RPLC assay method. J Pharm Biomed Anal 25 : 191 195.
169. Thoppil SO, Cardoza RM, Amin PD (2001) Stability indicating HPTLC determination of trimetazidine as bulk drug and in pharmaceutical formulations. J Pharm Biomed Anal 25 : 15 20.
170. Toda N, Usui H, Osumi S, Kanda M, Kitao K (1982) Influence of trimetazidine, an antianginal drug, on isolated dog arteries and veins. Arch Int Pharmacodyn Ther 260 : 230 243.
171. Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S (2006) The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow. J Electrocardiol 39 : 211 218.
172. Tritto I, Wang P, Kuppusamy P, Giraldez R, Zweier JL, Ambrosio G (2005) The anti-anginal drug trimetazidine reduces neutrophil-mediated cardiac reperfusion injury. J Cardiovasc Pharmacol 46 : 89 98.
173. Tsimoyiannis EC, Moutesidou KJ, Moschos CM, Karayianni M, Karkabounas S, Kotoulas OB (1993) Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats. Eur J Surg 159 : 89 93.
174. Uslu B, Ozkan SA (2007a) Electroanalytical application of carbon based electrodes to the pharmaceuticals. Anal Lett 40 : 817 853.
175. Uslu B, Ozkan SA (2007b) Solid electrodes in electroanalytical chemistry: Present applications and prospects for high throughput screening of drug compounds. Comb Chem High T Scr 10 : 495 513.
176. Wang J (2000) Analytical electrochemistry, 2nd Edition. New York : Wiley-VCH.
177. Wang ZB, Sun J, Rong R, Tang JL, He ZG (2007) Quantification of trimetazidine in human plasma by liquid chromatography-electrospray ionization mass spectrometry and its application to a bioequivalence study. Pharmazie 62 : 27 30.
178. Yanagisawa T, Satoh K, Taira N (1979) Simultaneous assessment of the effects of trimetazidine on the myocardium and coronary vasculature of the dog. Arch Int Pharmacodyn Ther 237 : 316 329.
179. Zini R, Simon N, Morin C, d'Athis P, Tillement JP (1996) Inhibition of rat cerebral mitochondrial respiration by cyclosporins A, D, and G and restoration with trimetazidine. C R Acad Sci III 319 : 1087 1092.